Media Mentions on Regulatory Research & Real-World Data Insights

View Media Mentions

Feb 4, 2025

PhaseV and Alimentiv to support execution of adaptive clinical trials for GI

Feb 3, 2025

GI-focused CRO Alimentiv ups trial tech with PhaseV’s adaptive machine learning software

Jan 27, 2025

Seven new drug discovery deals powered by AI

Jan 17, 2025

PhaseV Advances Machine Learning-Driven Lupus Research in New Toronto Collaboration

Nov 26, 2024

Seven Top Pharma Companies Adopt PhaseV's Machine Learning Technology for Drug Development

Nov 12, 2024

How A.I. Is Disrupting Pharma: The High-Stakes Race to Revolutionize Drug Discovery

Oct 30, 2024

PhaseV Appoints Hamza Sheikh as Head of Business Development

Sep 12, 2024

PhaseV Unveils Machine Learning-Powered Platform to Improve Oncology Clinical Trials - BioQuick News

Jul 12, 2024

Marks: FDA Struggles To Keep Up With Innovation In Gene Editing, AI

Jun 21, 2024

ML could facilitate increased adoption of adaptive clinical trials - Drug Discovery World (DDW)

Jun 17, 2024

New ML-Powered Solution to Increase Success Rates of Phase 3 Oncology Trials - European Pharmaceutical Manufacturer

Mar 6, 2024

PhaseV and Quanticate partner to help sponsors run more adaptive trialsPhaseV and iOMEDICO Partner to Launch New ML-Powered Solution to Increase Success Rates of Phase 3 Oncology Trials | BioSpace

Feb 29, 2024

Sustainability challenges in rare disease trials remain, but change is happening

Nov 7, 2023

9xchange Biopharma Marketplace Partners with PhaseV to Bring ML-Powered Clinical Trial Optimization Technology to Ecosystem Members

Oct 24, 2023

PhaseV raise $15m for ML technology to optimise trial design

Oct 24, 2023

Media Mentions on Regulatory Research & Real-World Data Insights

PhaseV and Alimentiv to support execution of adaptive clinical trials for GI

GI-focused CRO Alimentiv ups trial tech with PhaseV’s adaptive machine learning software

Seven new drug discovery deals powered by AI

PhaseV Advances Machine Learning-Driven Lupus Research in New Toronto Collaboration

Seven Top Pharma Companies Adopt PhaseV's Machine Learning Technology for Drug Development

How A.I. Is Disrupting Pharma: The High-Stakes Race to Revolutionize Drug Discovery

PhaseV Appoints Hamza Sheikh as Head of Business Development

PhaseV Unveils Machine Learning-Powered Platform to Improve Oncology Clinical Trials - BioQuick News

Marks: FDA Struggles To Keep Up With Innovation In Gene Editing, AI

ML could facilitate increased adoption of adaptive clinical trials - Drug Discovery World (DDW)

DIA 2024: Machine Learning and Simulations to Facilitate Clinical Trials

Machine learning drafted to aid Phase 3 testing of ALS therapy PrimeC

NeuroSense taps PhaseV’s ML tech for Phase III ALS trial analysis

Quanticate and PhaseV partner on new adaptive clinical trial service

New ML-Powered Solution to Increase Success Rates of Phase 3 Oncology Trials - European Pharmaceutical Manufacturer

PhaseV and Quanticate partner to help sponsors run more adaptive trialsPhaseV and iOMEDICO Partner to Launch New ML-Powered Solution to Increase Success Rates of Phase 3 Oncology Trials | BioSpace

Sustainability challenges in rare disease trials remain, but change is happening

9xchange Biopharma Marketplace Partners with PhaseV to Bring ML-Powered Clinical Trial Optimization Technology to Ecosystem Members

PhaseV raise $15m for ML technology to optimise trial design

PhaseV reaps $15M in funding to streamline trial design with machine learning

Ready to Optimize Your Clinical Trials?